Stanford Home
Ovarian Kaleidoscope Database (OKdb)

Home

History

Transgenic Mouse Models

INFORGRAPHICS

Search
Submit
Update
Chroms
Browse
Admin

Hsueh lab

HPMR

Visits
since 01/2001:
176557

Carnitine Palmitoyltransferase Ii OKDB#: 3574
 Symbols: CPT2 Species: human
 Synonyms: CPT1, CPTASE,CPT II  Locus: 1p32 in Homo sapiens


For retrieval of Nucleotide and Amino Acid sequences please go to: OMIM Entrez Gene
Mammalian Reproductive Genetics   Endometrium Database Resource   Orthologous Genes   UCSC Genome Browser   GEO Profiles new!   Amazonia (transcriptome data) new!

R-L INTERACTIONS   MGI

DNA Microarrays
SHOW DATA ...
link to BioGPS
General Comment NCBI Summary: Carnitine palmitoyltransferase II precursor (CPT2) is a nuclear protein which is transported to the mitochondrial inner membrane. CPT2 together with carnitine palmitoyltransferase I oxidizes long-chain fatty acids in the mitochondria. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders.
General function Enzyme, Transferase
Comment
Cellular localization Mitochondrial
Comment
Ovarian function
Comment
Expression regulated by
Comment
Ovarian localization Oocyte, Cumulus
Comment Fatty Acid Metabolism during Maturation Affects Glucose Uptake and is Essential to Oocyte Competence. Paczkowski M 2014 et al. Fatty acid oxidation (FAO) is essential for oocyte maturation in mice. The objective of this experiment was to determine the effect of etomoxir (a FAO inhibitor; 100 M), carnitine (1 mM), and palmitic acid (1 or 100 M) during maturation on metabolism and gene expression of the oocyte and cumulus cells, and subsequent embryo development in the mouse. Carnitine significantly increased embryo development, while there was a decrease in development following maturation with 100 M palmitic acid or etomoxir (P<0.05). Glucose consumption per cumulus-oocyte-complex (COC) was decreased after treatment with carnitine and increased following etomoxir treatment (P<0.05). Intracellular oocyte lipid content was decreased after carnitine or etomoxir exposure (P<0.05). Abundance of Glut1 was increased after etomoxir treatment in the oocyte and cumulus cells (P<0.05), suggesting stimulation of glucose transport and potentially the glycolytic pathway for energy production when FAO is inhibited. Abundance of Cpt2 tended to increase in oocytes (P=0.1) after treatment with 100 M palmitic acid and in cumulus cells after exposure to 1 M palmitic acid (P=0.07). Combined with carnitine, 1 M palmitic acid increased abundance of Acsl3 (P<0.05) and Cpt2 tended to increase (P=0.07) in cumulus cells, suggesting FAO was increased during maturation in response to stimulators and fatty acids. In conclusion, fatty acid and glucose metabolism are related in the mouse COC, as inhibition of FAO increases glucose consumption. Stimulation of FAO decreases glucose consumption and lipid stores, positively affecting subsequent embryo development, while an overabundance of fatty acid or reduced FAO negatively affects oocyte quality. /////////////////////////
Follicle stages
Comment
Phenotypes
Mutations 0 mutations
Genomic Region show genomic region
Phenotypes and GWAS show phenotypes and GWAS
Links
OMIM (Online Mendelian Inheritance in Man: an excellent source of general gene description and genetic information.)
OMIM \ Animal Model
KEGG Pathways
Recent Publications
None
Search for Antibody


created: Sept. 13, 2006, 4:55 p.m. by: amazinmazin   email:
home page:
last update: April 17, 2015, 12:53 p.m. by: hsueh    email:



Use the back button of your browser to return to the Gene List.

Click here to return to gene search form